冠状病毒疾病-2019在免疫功能低下的主体中
Christopher D Bertini1, Fareed Khawaja2, Ajay Sheshadri3
1Department of Internal Medicine, UTHealth Houston McGovern Medical School, 6431 Fannin, MSB 1.150, Houston, TX 77030, USA.
免疫功能低下的患者面临COVID-19的严重后果,包括更高的住院和死亡率. 目前的治疗方法和疫苗的有效性各不相同,这凸显了针对这一弱势群体的具体策略的必要性.
科学领域:
- 传染病和病毒学 传染病和病毒学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 免疫功能低下的个体,包括患有恶性瘤,接受移植或患有自身免疫性疾病的人,患重症COVID-19的风险增加.
- 与免疫能力强的人群相比,这种人群在2019年新冠病毒病 (COVID-19) 的发病率和死亡率不成比例地更高.
- 现有的治疗和预防措施,如疫苗和单克隆抗体,在免疫受损的宿主中表现出有限和可变的疗效.
研究的目的:
- 审查COVID-19对免疫受损患者群体的特定影响.
- 识别和分析有关免疫功能低下个体COVID-19管理的现有知识差距.
- 突出需要进一步研究的领域,以改善患者的治疗结果.
主要方法:
- 综合文献综述,重点研究详细介绍COVID-19在免疫受损宿主中的研究.
- 分析与免疫状况相关的疾病严重程度,住院和死亡率的数据.
- 评估当前干预措施的有效性,包括疫苗,单克隆抗体和康复期血.
主要成果:
- 免疫功能低下的患者表现出明显更严重的COVID-19疾病,导致住院和死亡率更高.
- 现有的疫苗,单克隆抗体和康复性血疗法的疗效在不同免疫性受损子组之间不一致.
- 缺乏专门针对COVID-19的免疫功能低下个体的既定,量身定制的治疗指南.
结论:
- 免疫功能低下的患者代表了一个关键人群,对严重的COVID-19结果的脆弱性增加.
- 当前的治疗和预防策略的有效性有所变化,这突显了对专门方法的迫切需要.
- 进一步的研究是必要的,以解决知识差距,并开发针对这一患者群的有针对性的干预措施.
更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
相关概念视频
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Stages of Infection
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
